{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:38:56Z","timestamp":1761863936156,"version":"3.41.2"},"reference-count":13,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2019.00046","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T04:29:35Z","timestamp":1549427375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence"],"prefix":"10.3389","volume":"9","author":[{"given":"Aixa E.","family":"Soyano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Candice","family":"Baldeo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pashtoon M.","family":"Kasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Crowley","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s00428-017-2137-8","article-title":"Liquid biopsy: unlocking the potentials of cell-free DNA","volume":"471","author":"Chu","year":"2017","journal-title":"Virchows Arch"},{"key":"B4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1186\/s12885-018-4433-3","article-title":"Update on the types and usage of liquid biopsies in the clinical setting: a systematic review","volume":"18","author":"Arneth","year":"2018","journal-title":"BMC Cancer"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.exphem.2018.06.003","article-title":"Circulating tumor DNA in blood: future genomic biomarkers for cancer detection","volume":"65","author":"Sumbal","year":"2018","journal-title":"Exp Hematol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"35289","DOI":"10.18632\/oncotarget.13311","article-title":"Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab","volume":"8","author":"Toledo","year":"2017","journal-title":"Oncotarget"},{"key":"B8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12885-016-2992-8","article-title":"Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report","volume":"17","author":"Namlos","year":"2017","journal-title":"BMC Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s12185-018-2487-2","article-title":"Circulating tumor DNA dynamically predicts response and\/or relapse in patients with hematological malignancies","volume":"108","author":"Nakamura","year":"2018","journal-title":"Int J Hematol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S838","DOI":"10.21037\/jtd.2018.04.08","article-title":"The role of liquid biopsy in predicting post-operative recurrence of non-small cell lung cancer","volume":"10","author":"Liang","year":"2018","journal-title":"J Thorac Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"7686","DOI":"10.1038\/ncomms8686","article-title":"Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients","volume":"6","author":"Sausen","year":"2015","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"700","DOI":"10.4161\/cbt.12.8.15960","article-title":"Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy","volume":"12","author":"Ren","year":"2011","journal-title":"Cancer Biol Ther"},{"key":"B13","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1073\/pnas.1704961114","article-title":"Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers","volume":"114","author":"Cohen","year":"2017","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00046\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T04:29:36Z","timestamp":1549427376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2019.00046\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":13,"alternative-id":["10.3389\/fonc.2019.00046"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2019.00046","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"article-number":"46"}}